An innovative treatment for B cell lymphoma could hold the key for a new generation of precision cancer therapy, researchers have reported.
A team led by researchers at Stanford University, California, have developed the new treatment in the labor...
10 months ago
Researchers have suggested a way of reducing the risk of infection faced by cancer patients receiving immune checkpoint inhibitor treatment.
The research, published in the journal Immunity, points to B cells being affected by the treatment, meanin...
10 months ago
